Toggle Main Menu Toggle Search

Open Access padlockePrints

Cognitive behavioural therapy skills using a smartphone app for subthreshold depression among adults in the community: the RESiLIENT randomised controlled trial

Lookup NU author(s): Professor James WasonORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Subthreshold depression, defined as a depressive status falling short of the diagnostic threshold for major depression, is common, disabling and constitutes a risk factor for future depressive episodes. Cognitive behavioral therapies (CBT) have been shown to be effective but are usually provided as packages of various skills. Little research has been done to investigate whether all their components are beneficial and contributory to mental health promotion. We addressed this issue by developing a smartphone CBT app that implements five representative CBT skills (behavioral activation, cognitive restructuring, problem solving, assertion training and behavior therapy for insomnia), and conducting a master randomized study that included four 2 × 2 factorial trials to enable precise estimation of skill-specific efficacies. Between September 2022 and February 2024, we recruited 3,936 adult participants with subthreshold depression. Among those randomized, the follow-up rate was 97% at week 6 and adherence to the app was 84%. The study showed that all included CBT skills and their combinations differentially beat all three control conditions of delayed treatment, health information or self-check, with effect sizes ranging between −0.67 (95% confidence interval: −0.81 to −0.53) and −0.16 (−0.30 to −0.02) for changes in depressive symptom severity from baseline to week 6, as measured with the Patient Health Questionnaire-9 scores. Knowledge of the active ingredients of CBT can better inform the design of more effective and scalable psychotherapies in the future. (UMIN Clinical Trials Registry UMIN000047124).


Publication metadata

Author(s): Furukawa TA, Tajika A, Toyomoto R, Sakata M, Luo Y, Horikoshi M, Akechi T, Kawakami N, Nakayama T, Kondo N, Fukuma S, Kessler RC, Christensen H, Whitton A, Nahum-Shani I, Lutz W, Cuijpers P, Wason JMS, Noma N

Publication type: Article

Publication status: Published

Journal: Nature Medicine

Year: 2025

Volume: 31

Pages: 1830-1839

Print publication date: 01/06/2025

Online publication date: 23/04/2025

Acceptance date: 05/03/2025

Date deposited: 12/03/2025

ISSN (print): 1078-8956

ISSN (electronic): 1546-170X

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41591-025-03639-1

DOI: 10.1038/s41591-025-03639-1

ePrints DOI: 10.57711/ecqj-kn91

Data Access Statement: Deidentified individual participant data and data dictionary will be made available 24 months after publication on UMIN-ICDR, an individual case data repository managed by the Japanese University Hospital Medical Information Network (UMIN) Center (https://www.umin.ac.jp/icdr/index.html). Proposals with specific aims and an analysis plan should be directed to the corresponding author, T.A.F. (furukawa@kuhp.kyoto-u.ac.jp). The decision will be made within a month. Code availability: R code files used in the statistical analyses are available on GitHub at https://github.com/nomahi/RESiLIENT.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Japan Agency for Medical Research and Development (AMED) (grant no. JP21de0107005)

Share